Back to DRIEHAUS CAPITAL MANAGEMENT LLC DRIEHAUS CAPITAL MANAGEMENT LLC

DRUGDRUG
3 quarters

Position history for DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC's holdings in BRIGHT MINDS BIOSCIENCES INC

Yes. Driehaus Capital Management holds 433,377 shares of DRUG (Bright Minds Biosciences), worth $30.4M, as of its Q2 2026 13F filing. It increased the position by 862 shares (+0.2%) from Q1 2026. Driehaus Capital Management has held DRUG since Q4 2025, across 3 quarterly 13F filings. DRUG is 0.2% of Driehaus Capital Management's reported 13F portfolio.

Current Value

$30.4M

Current Shares

433,377

Total Value Change

+$9.4M

Total Shares Change

+163,736

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
433,377
+0.2%
$30.4M0.2%$70.20
34
2026-Q1
Increased
432,515
+60.4%
$31.6M0.2%$80.00
50
2025-Q4
New
269,641
-
$21M0.1%$75.85
47

Other major holders of DRUG: Jupiter Topco LLC, Janus Henderson Group Ltd., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used